Brinker Capital Investments, LLC Marker Therapeutics, Inc. Transaction History

Brinker Capital Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.37 - $1.0 $8,041 - $21,733	-21,733 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$0.95 - $1.72 $7,190 - $13,018	-7,569 Reduced 25.83%	21,733 $21,000
Q2 2021 Aug 03, 2021	BUY	$1.88 - $3.56 $1,609 - $3,047	856 Added 3.01%	29,302 $82,000
Q1 2021 May 12, 2021	BUY	$1.47 - $3.29 $41,815 - $93,587	28,446 New	28,446 $64,000

472K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $242M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.